ALL
Pharma in China
Pharma Experts
Market News
Products Guide
Brand Story
-
EdiGene and Neukio enter collaboration to develop next-generation immune cell therapies
February 14, 2022EdiGene, Inc and Neukio Biotherapeutics have announced an R&D collaboration to develop next-generation immune cell therapies, Neukio Biotherapeutics informed via a statement. -
Neukio Biotherapeutics completed its $40m Angel round financing, focusing on the development of iPSC-CAR-NK platform and assets.
July 30, 2021Neukio Biotherapeutics, a newly established company, recently announced the completion of its $40m Angel round of financing led by Lilly Asia Venture (LAV), with the participation of IDG Capital and Sherpa Investments.
Pharma Sources Insight January 2025
